IART Financials
Integra Lifesciences Holdings Corp - Financial statements & key metrics
Stock Price
$11.14
Market Cap
$844.84M
EPS
$-6.74
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$1.61B
Gross Profit
-
Operating Income
-
Net Income
$-6.94M
EPS (Diluted)
$-0.09
Balance Sheet Highlights
Total Assets
$4.04B
Total Liabilities
$2.49B
Shareholders Equity
-
Cash & Equivalents
$246.38M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$129.38M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
56.2%
Operating Margin
0.1%
Net Margin
-0.3%
ROE
-0.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is IART revenue?
IART's most recent quarterly revenue was $1.61B. Annual revenue can be calculated by summing the four most recent quarters.
Is IART profitable?
IART reported a loss of $6.94M in the most recent quarter. The net profit margin is -0.3%.
What is IART market cap?
IART has a market capitalization of $844.84M, making it a small-cap stock.
Does IART have debt?
View IART's balance sheet for debt information.
What is IART cash flow?
Cash flow data is available in the full financial statements.